Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esketamine and remimazolam for painless induced abortion and postoperative depression
ChiCTR2100047306Phase 4Recruiting
- Sponsor
- Affiliated Hospital of Guizhou Medical University
- Start
- Jul 2021
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of esketamine, remimazolam, propofol and fentanyl in Induced Abortion (TOP) (4 arms), sponsored by Affiliated Hospital of Guizhou Medical University. Primary endpoint: Success rate of operation. Started Jul 2021; status: recruiting.
02
Drugs
esketamineremimazolampropofolfentanyl
03
Conditions
Induced Abortion (TOP)
Beyond the preview
Go deeper on ChiCTR2100047306.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100047306.